personalised medicine

R&D

science laboratory research and development

The role of quality assurance in accelerating drug developme...

The pharmaceutical landscape is experiencing a paradigm shift with the rise of gene therapies, cell therapies, and personalised medicine.

Oncology

Strategies for commercialising oncology treatments for young...

The oncology landscape is evolving, with a marked rise in cancer incidence among young adults globally.

R&D

Myeloma multiplex leukaemia cancer 3D render

The future of multiple myeloma is personalised, but we must ...

It’s true that we’ve come a long way in recent years when it comes to treating multiple myeloma.

News

Job losses loom at Achilles as TIL therapy platform is cut

Employees at Achilles Therapeutics are bracing themselves for job losses after the UK biotech announced that it is dropping its R&D in tumour-infiltrating lymphocyte (TIL) therapies for

Market Access

Overcoming regulatory hurdles to unleash breakthrough innova...

The life sciences industry is currently undergoing a significant transformation, driven by the rapid development of new modalities such as cell and gene therapies (CAGT), and substantial ne

Digital